Prevalence of Coronary Artery Disease in Symptomatic Patients with Zero CAC Score by Age Group
Yan-Ting Yu, Zhi-Hui Hou, Bin Lu · Cross-sectional study
BlueRipple Assessment
This cross-sectional study examined 5,514 symptomatic patients referred for CCTA who were found to have a CAC score of zero, characterizing the prevalence of non-calcified plaque and obstructive coronary artery disease by age group.
Among 5,514 patients with CACS=0, 25.3% had identifiable coronary plaque (non-calcified, invisible to calcium scoring), and 9.3% had obstructive CAD (≥50% stenosis) by CCTA. Prevalence of both non-calcified plaque and obstructive CAD increased significantly with age: obstructive CAD with CACS=0 was uncommon below age 50 but reached clinically significant prevalence in older patients.
This study directly addresses the critical question about the CAC=0 “warranty period.” In asymptomatic individuals, CACS=0 is associated with very low event rates over follow-up (Valenti et al., 2015). But this study examines symptomatic patients — those referred for evaluation specifically because of chest pain, dyspnea, or other cardiac symptoms — in whom CACS=0 does not exclude significant non-calcified plaque or even obstructive CAD.
The distinction between symptomatic and asymptomatic contexts is fundamental. In asymptomatic primary prevention patients, CACS=0 appropriately supports deferral of further testing and therapy. In symptomatic patients where CAD is clinically suspected, CACS=0 does not exclude CAD requiring CCTA for definitive assessment.
We rate the evidence moderate. A large cross-sectional study demonstrating that 9.3% of symptomatic patients with zero CAC have obstructive CAD — important evidence clarifying that CACS=0 does not exclude significant CAD in symptomatic patients, who require CCTA rather than calcium scoring alone.
The original source
Yu YT, Hou ZH, Lu B, et al. Prevalence of coronary artery disease in symptomatic patients with zero coronary artery calcium score in different age population. Int J Cardiovasc Imaging. 2021 Feb;37(2):723–729.
BlueRipple Health provides consumer education and research synthesis for informed health advocacy. This is not medical advice. Discuss all health decisions with a qualified clinician.